Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Augmedix Q4 Sales $6.60M Beat $6.40M Estimate

Augmedix (NASDAQ:AUGX) reported quarterly sales of $6.60 million which beat the analyst consensus estimate of $6.40 million by 3.13 percent.
byBill Haddad
March 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Augmedix (NASDAQ:AUGX) reported quarterly sales of $6.60 million which beat the analyst consensus estimate of $6.40 million by 3.13 percent.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

The Intersection Of Cannabis & Consumer Products: These Non-Cannabis Companies Are Benefiting From The Growing Industry

By Wayne Duggan
Today, 10:27 AM
Cannabis stocks have struggled in the market in recent years. But while the cannabis industry itself is still struggling to gain ground on the regulatory front, plenty of companies outside the industry are benefitting from the rising popularity of cannabis products. 

AMZN